MustGrow Biologics Corp. press release
Hydrogel Injection Could Change Cardiac Tissue Healing After Heart Attacks
TSXV - TSX Venture Exchange · Canada
Researchers at Spain’s University of Valladolid, BIOFORGE Labs, the SFI Research Center and CÚRAMhave created a hydrogel injectablethat may prevent additional damage and assist in repairing heart muscles following a heart attack.
Heart disease, or myocardial infarction, is the most common cause of death owing to irreversible damage of cardiac tissue after a heart attack. As tissue regeneration is minimal, any damage to heart muscle...
Read more »
NOTE TO INVESTORS: The latest news and updates relating to MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) are available in the company’s newsroom at http://ibn.fm/MGROF
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services viaInvestorWireto reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text "STOCKS" to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW) San Francisco, California www.BioMedWire.com 415.949.5050 Office Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
Earlier from MustGrow Biologics Corp.
- BioMedNewsBreaks - MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) Isolates and Concentrates a Mustard-Derived Molecule that Acts as a Systemic, Non-Selective Bioherbicide
- MustGrow Isolates and Concentrates a Mustard-Derived Molecule that Acts as a Systemic, Non-Selective Bioherbicide
- MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) Reports Its Plant-Based Biopesticide Has Positive Impact on Soil Health